Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer | BeOne Medicines

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

Beigene Study ID

BGB-290-303

ClinicalTrials.gov ID

NCT03427814

EudraCT Number

2017-003493-13

China Drug Trials ID

CTR20171664

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

Study Documents

Study Protocol Statistical Analysis Plan